Your browser doesn't support javascript.
loading
Interleukin-15 enhances rituximab-dependent cytotoxicity against chronic lymphocytic leukemia cells and overcomes transforming growth factor beta-mediated immunosuppression.
Moga, Esther; Cantó, Elisabet; Vidal, Silvia; Juarez, Cándido; Sierra, Jorge; Briones, Javier.
Affiliation
  • Moga E; Department of Immunology, Hospital Santa Creu i Sant Pau, Barcelona, Spain.
Exp Hematol ; 39(11): 1064-71, 2011 Nov.
Article in En | MEDLINE | ID: mdl-21864486
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell / Transforming Growth Factor beta / Immunosuppression Therapy / Interleukin-15 / Antibodies, Monoclonal, Murine-Derived / Antibody-Dependent Cell Cytotoxicity Limits: Humans Language: En Journal: Exp Hematol Year: 2011 Type: Article Affiliation country: Spain
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell / Transforming Growth Factor beta / Immunosuppression Therapy / Interleukin-15 / Antibodies, Monoclonal, Murine-Derived / Antibody-Dependent Cell Cytotoxicity Limits: Humans Language: En Journal: Exp Hematol Year: 2011 Type: Article Affiliation country: Spain